News and Announcements
Biorithm featured in Medical Festival Asia 2020
- Published February 26, 2021 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Biorithm’s novel femom remote monitoring system was featured at the Medical Festival Asia in two panels discussing new technologies in healthcare and women’s health.
The first panel featured Prof Basky Thilaganathan, Professor of fetal medicine at St George’s University, London, discussing the need for new technologies to address gaps in care in obstetrics and how femom could provide both clinical as well as workflow improvements in the NHS.
The second panel featuring Dr Deboarh Fox, Senior Lecturer for Midwifery at UTS, Sydney, Dr Christina Low, MD for Singapore Medical Group and Amrish Nair, Co-Founder of Biorithm, discussed how to keep obstetrics care human in the age of technology. Amrish amplified Biorithm’s mission to improve the patient experience and using digital as a tool to improve quality of care rather than replace care altogether.
Through these panels, Biorithm aims to foster improvement of obstetric care by engaging to top clinical minds in the field.
About Biorithm
Biorithm provides innovative maternal-fetal connected care solution to improve pregnancy outcomes for patients and healthcare providers.
Forging new frontiers in pregnancy care, Biorithm has developed cutting edge analytic software together with medical-grade abdominal ECG wearable designed for remote monitoring of maternal & fetal physiological parameters.
Our unique solution allows accurate monitoring of a wide range of vital pregnancy data, empowering patient and clinicians to identify early signs of maternal-fetal complication for timely intervention while reducing the cost of care.
Founded by doctors and engineers, Biorithm is a medical technology start-up spun-off from Nanyang Technological University in Singapore. We believe that comprehensive maternal healthcare should leverage the power of digital health and advanced sensors to address individual patient and clinicians needs, enhance data-driven decisions, complication prevention, and provide access to affordable and preventive care.
Company Updates
The asset class where the market has no vote
Litigation funding returns are decided in a courtroom, not a cycle. Knightsbridge’s Head of Capital is careful to call that a different risk rather than a lower one, and his answer to it is spread, not concentration. Most alternative assets still answer to something. Property answers to rates. Private credit answers to defaults. Even the […]
The listing fee vendors pay whether the house sells or not
Australia’s property portals collect more than $2 billion a year while national listings sit flat. An Australian-built AI platform is targeting the economics, not just the interface. An Australian vendor listing a home pays a vendor-paid advertising fee on top of agency commission. Rama Dwarapudi, Founder and Chief Executive Officer of RealSearch, puts a typical […]
Reinventing the Condom: How an Australian Deep-Tech Startup Plans to Disrupt a $12 Billion Market
For more than half a century, the global condom industry has remained fundamentally unchanged, constrained by standard materials like latex and solid synthetic polymers. Despite widespread consumer demand for better alternatives, product design has treated the device strictly as a mechanical barrier, sacrificing feel for function. Sydney-based Eudaemon Technologies is setting out to upend that […]
Backed By Leading Investment Groups and Family Offices
